Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes

References

• Nalysnyk L, Hernandez-Medina M, Krishnarajah G. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab. 2010;12:288–298.
   PubMed Web of Science ®Google Scholar
• (NCD-RisC) NRFC. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016; 387:1513–1530.
   PubMed Web of Science ®Google Scholar
• Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. Pharmacoeconomics. 2015;33:811–831.
   PubMed Web of Science ®Google Scholar
• da Rocha Fernandes J, Ogurtsova K, Linnenkamp U, et al. IDF diabetes atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract. 2016;117:48–54.
   PubMed Web of Science ®Google Scholar
• Ginter E, Simko V. Global prevalence and future of diabetes mellitus. Adv Exp Med Biol. 2012;771:35–41.
   PubMed Web of Science ®Google Scholar
• Adeghate E, Schattner P, Dunn E. An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci. 2006;1084:1–29.
   PubMed Web of Science ®Google Scholar
• Waugh N, Scotland G, McNamee P, et al. Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess. 2007;11:iii–iiv, ix–xi, 1–125.
   Web of Science ®Google Scholar
• Waugh NR, Shyangdan D, Taylor-Phillips S, et al. Screening for type 2 diabetes: a short report for the national screening committee. Health Technol Assess. 2013;17:1–90.
   PubMed Web of Science ®Google Scholar
• Saudek CD, Herman WH, Sacks DB, et al. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008;93:2447–2453.
   PubMed Web of Science ®Google Scholar
• Pippitt K, Li M, Gurgle HE. Diabetes mellitus: screening and diagnosis. Am Fam Physician. 2016;93: 103–109.
   PubMed Web of Science ®Google Scholar
• Kramer CK, Zinman B, Choi H, et al. Predictors of sustained drug-free diabetes remission over 48 weeks following short-term intensive insulin therapy in early type 2 diabetes. BMJ Open Diabetes Res Care. 2016;4:e000270.
   PubMed Web of Science ®Google Scholar
• Gregg EW, Chen H, Wagenknecht LE, et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012;308: 2489–2496.
   PubMed Web of Science ®Google Scholar
• Redmon JB, Bertoni AG, Connelly S, et al. Effect of the look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes. Diabetes Care. 2010;33:1153–1158.
   PubMed Web of Science ®Google Scholar
• Tildesley HD, Conway ME, Deng L, et al. The effectiveness of internet intervention on 926 patients with diabetes mellitus for up to 30 months. Can J Diabetes. 2015;39:216–220.
   PubMed Web of Science ®Google Scholar
• Ramli AS, Selvarajah S, Daud MH, et al. Effectiveness of the EMPOWER-PAR intervention in improving clinical outcomes of type 2 diabetes mellitus in primary care: a pragmatic cluster randomised controlled trial. BMC Fam Pract. 2016;17:157.
   PubMed Web of Science ®Google Scholar
• Schutz Y. Protein turnover, ureagenesis and gluconeogenesis. Int J Vitam Nutr Res. 2011;81:101–107.
   PubMed Web of Science ®Google Scholar
• Chung ST, Hsia DS, Chacko SK, et al. Increased gluconeogenesis in youth with newly diagnosed type 2 diabetes. Diabetologia. 2015;58:596–603.
   PubMed Web of Science ®Google Scholar
• Basu R, Chandramouli V, Dicke B, et al. Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes. 2005;54:1942–1948.
   PubMed Web of Science ®Google Scholar
• Bender DA. The metabolism of “surplus” amino acids. Br J Nutr. 2012;108(2):S113–S121.
   Web of Science ®Google Scholar
• Wester TJ, Kraft G, Dardevet D, et al. Nutritional regulation of the anabolic fate of amino acids within the liver in mammals: concepts arising from in vivo studies. Nutr Res Rev. 2015;28:22–41.
   PubMed Web of Science ®Google Scholar
• Jungas RL, Halperin ML, Brosnan JT. Quantitative analysis of amino acid oxidation and related gluconeogenesis in humans. Physiol Rev. 1992;72:419–448.
   PubMed Web of Science ®Google Scholar
• Brooks GA. Amino acid and protein metabolism during exercise and recovery. Med Sci Sports Exerc. 1987;19:S150–S156.
   PubMed Web of Science ®Google Scholar
• Wu G. Amino acids: metabolism, functions, and nutrition. Amino Acids. 2009;37:1–17.
   PubMed Web of Science ®Google Scholar
• Gannon MC, Nuttall FQ. Amino acid ingestion and glucose metabolism-a review. IUBMB Life. 2010;62: 660–668.
   PubMed Web of Science ®Google Scholar
• Unger RH, Orci L. Physiology and pathophysiology of glucagon. Physiol Rev. 1976;56:778–826.
   PubMed Web of Science ®Google Scholar
• Berger S, Vongaraya N. Insulin response to ingested protein in diabetes. Diabetes. 1966;15:303–306.
   PubMed Web of Science ®Google Scholar
• Fajans SS, Floyd JC Jr. Knopf RF, et al. Effect of amino acids and proteins on insulin secretion in man. Recent Prog Horm Res. 1967;23:617–662.
   PubMedGoogle Scholar
• Davids M, Peters JH, de Jong S, et al. Measurement of nitric oxide-related amino acids in serum and plasma: effects of blood clotting and type of anticoagulant. Clin Chim Acta. 2013;421:164–167.
   PubMed Web of Science ®Google Scholar
• Denery JR, Nunes AA, Dickerson TJ. Characterization of differences between blood sample matrices in untargeted metabolomics. Anal Chem. 2011;83: 1040–1047.
   PubMed Web of Science ®Google Scholar
• Liu L, Aa J, Wang G, et al. Differences in metabolite profile between blood plasma and serum. Anal Biochem. 2010;406:105–112.
   PubMed Web of Science ®Google Scholar
• Xia T, Gao S, Shu C, et al. Analysis of amino acids in human blood using UHPLC-MS/MS: potential interferences of storage time and vacutainer tube in pre-analytical procedure. Clin Biochem. 2016;49: 1372–1378.
   PubMed Web of Science ®Google Scholar
• Lopez-Bascon MA, Priego-Capote F, Peralbo-Molina A, et al. Influence of the collection tube on metabolomic changes in serum and plasma. Talanta. 2016;150:681–689.
   PubMed Web of Science ®Google Scholar
• Barri T, Dragsted LO. UPLC-ESI-QTOF/MS and multivariate data analysis for blood plasma and serum metabolomics: effect of experimental artefacts and anticoagulant. Anal Chim Acta. 2013;768:118–128.
   PubMed Web of Science ®Google Scholar
• Wedge DC, Allwood JW, Dunn W, et al. Is serum or plasma more appropriate for intersubject comparisons in metabolomic studies? An assessment in patients with small-cell lung cancer. Anal Chem. 2011;83:6689–6697.
   PubMed Web of Science ®Google Scholar
• Jobard E, Tredan O, Postoly D, et al. A systematic evaluation of blood serum and plasma Pre-analytics for metabolomics cohort studies. Int J Mol sci. 2016;17:E2035.
   PubMed Web of Science ®Google Scholar
• Breier M, Wahl S, Prehn C, et al. Targeted metabolomics identifies reliable and stable metabolites in human serum and plasma samples. PLoS One. 2014;9:e89728.
   PubMed Web of Science ®Google Scholar
• Tessari P, Zanetti M, Barazzoni R, et al. Mechanisms of postprandial protein accretion in human skeletal muscle. Insight from leucine and phenylalanine forearm kinetics. J Clin Invest. 1996;98:1361–1372.
   PubMed Web of Science ®Google Scholar
• Synge RL. Analysis of a partial hydrolysate of gramicidin by partition chromatography with starch. Biochem J. 1944;38:285–294.
   PubMedGoogle Scholar
• Moore S, Stein WH. Procedures for the chromatographic determination of amino acids on four per cent cross-linked sulfonated polystyrene resins. J Biol Chem. 1954;211:893–906.
   PubMed Web of Science ®Google Scholar
• Moore S, Stein WH. Partition chromatography of amino acids on starch. Ann N Y Acad Sci. 1948;49: 265–278.
   PubMed Web of Science ®Google Scholar
• Stein WH, Moore S. The free amino acids of human blood plasma. J Biol Chem. 1954;211:915–926.
   PubMed Web of Science ®Google Scholar
• Stein WH, Moore S. Chromatographic determination of the amino acid composition of proteins. Cold Spring Harb Symp Quant Biol. 1950;14:179–190.
   PubMedGoogle Scholar
• Moore S, Stein WH. Photometric ninhydrin method for use in the chromatography of amino acids. J Biol Chem. 1948;176:367–388.
   PubMed Web of Science ®Google Scholar
• Moore S, Stein WH. Chromatography of amino acids; colorimetric ninhydrin method for analysis of the effluent. Fed Proc. 1948;7:174.
   PubMedGoogle Scholar
• Ogden G. Analysis in the ion exchange tradition. Nature. 1986;320:771.
   PubMed Web of Science ®Google Scholar
• Hirs CH, Moore S, Stein WH. Isolation of amino acids by chromatography on ion exchange columns; use of volatile buffers. J Biol Chem. 1952;195:669–696.
   PubMed Web of Science ®Google Scholar
• Spackman DH, Stein WH, Moore S. Automatic recording apparatus for use in the chromatography of amino acids. Fed Proc. 1958;17:1107–1115.
   PubMedGoogle Scholar
• Masuda A, Dohmae N. Amino acid analysis of sub-picomolar amounts of proteins by precolumn fluorescence derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate. Biosci Trends. 2011; 5:231–238.
   PubMed Web of Science ®Google Scholar
• Wernisch S, Pennathur S. Evaluation of coverage, retention patterns, and selectivity of seven liquid chromatographic methods for metabolomics. Anal Bioanal Chem. 2016;408:6079–6091.
   PubMed Web of Science ®Google Scholar
• Periat A, Boccard J, Veuthey J-L, et al. Systematic comparison of sensitivity between hydrophilic interaction liquid chromatography and reversed phase liquid chromatography coupled with mass spectrometry. J Chromatogr A. 2013;1312:49–57.
   PubMed Web of Science ®Google Scholar
• Zhang A, Sun H, Wang P, et al. Modern analytical techniques in metabolomics analysis. Analyst. 2012;137:293–300.
   PubMed Web of Science ®Google Scholar
• Dai W, Yin P, Zeng Z, et al. Nontargeted modification-specific metabolomics study based on liquid chromatography-high-resolution mass spectrometry. Anal Chem. 2014;86:9146–9153.
   PubMed Web of Science ®Google Scholar
• Ghaste M, Mistrik R, Shulaev V. Applications of Fourier Transform Ion Cyclotron Resonance (FT-ICR) and orbitrap based high resolution mass spectrometry in metabolomics and lipidomics. Int J Mol Sci. 2016;17:E816.
   PubMed Web of Science ®Google Scholar
• Liu Y, Smirnov K, Lucio M, et al. MetICA: independent component analysis for high-resolution mass-spectrometry based non-targeted metabolomics. BMC Bioinformatics. 2016;17:114.
   PubMed Web of Science ®Google Scholar
• Rubert J, Zachariasova M, Hajslova J. Advances in high-resolution mass spectrometry based on metabolomics studies for food–a review. Food Addit Contam Part A Chem Anal Control Exp Risk Assess. 2015;32:1685–1708.
   PubMed Web of Science ®Google Scholar
• Castro-Perez J, Plumb R, Granger JH, et al. Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer. Rapid Commun Mass Spectrom. 2005;19:843–848.
   PubMed Web of Science ®Google Scholar
• Plumb R, Castro-Perez J, Granger J, et al. Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry. Rapid Commun Mass Spectrom. 2004;18:2331–2337.
   PubMed Web of Science ®Google Scholar
• Banoei MM, Donnelly SJ, Mickiewicz B, et al. Metabolomics in critical care medicine: a new approach to biomarker discovery. Clin Invest Med. 2014;37:E363–E376.
   PubMed Web of Science ®Google Scholar
• Wang X, Sun H, Zhang A, et al. Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies. J Sep Sci. 2011;34:3451–3459.
   PubMed Web of Science ®Google Scholar
• Lee DY, Bowen BP, Northen TR. Mass spectrometry-based metabolomics, analysis of metabolite-protein interactions, and imaging. Biotechniques. 2010;49: 557–565.
   PubMed Web of Science ®Google Scholar
• Smilde AK, van der Werf MJ, Schaller JP, et al. Characterizing the precision of mass-spectrometry-based metabolic profiling platforms. Analyst. 2009;134:2281–2285.
   PubMed Web of Science ®Google Scholar
• Nováková L, Vlčková H. A review of current trends and advances in modern bio-analytical methods: chromatography and sample preparation. Anal Chim Acta. 2009;656:8–35.
   PubMed Web of Science ®Google Scholar
• Wolak JE, Esther CR Jr, O'Connell TM. Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients. Biomarkers. 2009;14:55–60.
   PubMed Web of Science ®Google Scholar
• Malet-Martino M, Holzgrabe U. NMR techniques in biomedical and pharmaceutical analysis. J Pharm Biomed Anal. 2011;55:1–15.
   PubMed Web of Science ®Google Scholar
• Serkova NJ, Niemann CU. Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics. Expert Rev Mol Diagn. 2006; 6:717–731.
   PubMed Web of Science ®Google Scholar
• Tang H, Xiao C, Wang Y. Important roles of the hyphenated HPLC-DAD-MS-SPE-NMR technique in metabonomics. Magn Reson Chem. 2009;47(1): S157–S162.
   Web of Science ®Google Scholar
• Pan Z, Raftery D. Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal Bioanal Chem. 2007;387:525–527.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yan L, Chen W, et al. Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system. Anal Chim Acta. 2009;650:16–22.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang Y, Hao F, et al. Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses. J Proteome Res. 2009;8:5188–5195.
   PubMed Web of Science ®Google Scholar
• Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311–326.
   PubMed Web of Science ®Google Scholar
• Tai ES, Tan ML, Stevens RD, et al. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia. 2010;53:757–767.
   PubMed Web of Science ®Google Scholar
• Fiehn O, Garvey WT, Newman JW, et al. Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One. 2010;5:e15234.
   PubMed Web of Science ®Google Scholar
• Gall WE, Beebe K, Lawton KA, et al. Alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One. 2010;5:e10883.
   PubMed Web of Science ®Google Scholar
• Suhre K, Meisinger C, Doring A, et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One. 2010;5:e13953.
   PubMed Web of Science ®Google Scholar
• Wurtz P, Tiainen M, Makinen VP, et al. Circulating metabolite predictors of glycemia in middle-aged men and women. Diabetes Care. 2012;35:1749–1756.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Qiu L, Xiao Q, et al. Obesity and diabetes related plasma amino acid alterations. Clin Biochem. 2013;46:1447–1452.
   PubMed Web of Science ®Google Scholar
• Menni C, Fauman E, Erte I, et al. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes. 2013;62:4270–4276.
   PubMed Web of Science ®Google Scholar
• Xu F, Tavintharan S, Sum CF, et al. Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics. J Clin Endocrinol Metab. 2013;98:E1060–E1065.
   PubMed Web of Science ®Google Scholar
• Kaur P, Rizk N, Ibrahim S, et al. Quantitative metabolomic and lipidomic profiling reveals aberrant amino acid metabolism in type 2 diabetes. Mol Biosyst. 2013;9:307–317.
   PubMed Web of Science ®Google Scholar
• Thalacker-Mercer AE, Ingram KH, Guo F, et al. BMI, RQ, diabetes, and sex affect the relationships between amino acids and clamp measures of insulin action in humans. Diabetes. 2014;63:791–800.
   PubMed Web of Science ®Google Scholar
• Geidenstam N, Spegel P, Mulder H, et al. Metabolite profile deviations in an oral glucose tolerance test-a comparison between lean and obese individuals. Obesity (Silver Spring, MD). 2014;22:2388–2395.
   PubMed Web of Science ®Google Scholar
• Mook-Kanamori DO, de Mutsert R, Rensen PC, et al. Type 2 diabetes is associated with postprandial amino acid measures. Arch Biochem Biophys. 2016;589:138–144.
   PubMed Web of Science ®Google Scholar
• Ho JE, Larson MG, Ghorbani A, et al. Metabolomic profiles of body mass index in the framingham heart study reveal distinct cardiometabolic phenotypes. PLoS One. 2016;11:e0148361.
   PubMed Web of Science ®Google Scholar
• Badoud F, Lam KP, Perreault M, et al. Metabolomics reveals metabolically healthy and unhealthy obese individuals differ in their response to a caloric challenge. PLoS One. 2015;10:e0134613.
   PubMed Web of Science ®Google Scholar
• Tulipani S, Palau-Rodriguez M, Minarro Alonso A, et al. Biomarkers of morbid obesity and prediabetes by metabolomic profiling of human discordant phenotypes. Clin Chim Acta. 2016;463:53–61.
   PubMed Web of Science ®Google Scholar
• Messana I, Forni F, Ferrari F, et al. Proton nuclear magnetic resonance spectral profiles of urine in type II diabetic patients. Clin Chem. 1998;44:1529–1534.
   PubMed Web of Science ®Google Scholar
• Zhang AH, Sun H, Yan GL, et al. Metabolomics study of type 2 diabetes using ultra-performance LC-ESI/quadrupole-TOF high-definition MS coupled with pattern recognition methods. J Physiol Biochem. 2014;70:117–128.
   PubMed Web of Science ®Google Scholar
• Cheng S, Rhee EP, Larson MG, et al. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation. 2012;125:2222–2231.
   PubMed Web of Science ®Google Scholar
• Guasch-Ferre M, Hruby A, Toledo E, et al. Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes Care. 2016;39:833–846.
   PubMed Web of Science ®Google Scholar
• Allam-Ndoul B, Guenard F, Garneau V, et al. Association between metabolite profiles, metabolic syndrome and obesity status. Nutrients. 2016;8:E324.
   PubMed Web of Science ®Google Scholar
• Bremer AA, Mietus-Snyder M, Lustig RH. Toward a unifying hypothesis of metabolic syndrome. Pediatrics. 2012;129:557–570.
   PubMed Web of Science ®Google Scholar
• Kamaura M, Nishijima K, Takahashi M, et al. Lifestyle modification in metabolic syndrome and associated changes in plasma amino acid profiles. Circ J. 2010;74:2434–2440.
   PubMed Web of Science ®Google Scholar
• Korsholm AS, Kjaer TN, Ornstrup MJ, et al. Comprehensive metabolomic analysis in blood, urine, fat, and muscle in men with metabolic syndrome: a randomized, placebo-controlled clinical trial on the effects of resveratrol after four months’ treatment. IJMS. 2017;18:E554.
   Google Scholar
• Org E, Blum Y, Kasela S, et al. Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort. Genome Biol. 2017;18:70.
   PubMed Web of Science ®Google Scholar
• Yamakado M, Nagao K, Imaizumi A, et al. Plasma free amino acid profiles predict four-year risk of developing diabetes, metabolic syndrome, dyslipidemia, and hypertension in Japanese population. Sci Rep. 2015;5:11918.
   PubMed Web of Science ®Google Scholar
• Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17:448–453.
   PubMed Web of Science ®Google Scholar
• Shah SH, Crosslin DR, Haynes CS, et al. Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia. 2012;55:321–330.
   PubMed Web of Science ®Google Scholar
• Stancakova A, Civelek M, Saleem NK, et al. Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men. Diabetes. 2012;61:1895–1902.
   PubMed Web of Science ®Google Scholar
• Wang-Sattler R, Yu Z, Herder C, et al. Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol. 2012;8:615.
   PubMed Web of Science ®Google Scholar
• Ferrannini E, Natali A, Camastra S, et al. Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes. 2013;62:1730–1737.
   PubMed Web of Science ®Google Scholar
• Floegel A, Stefan N, Yu Z, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013;62:639–648.
   PubMed Web of Science ®Google Scholar
• tWurtz P, Soininen P, Kangas AJ, et al. Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care. 2013;36:648–655.
   PubMed Web of Science ®Google Scholar
• Palmer ND, Stevens RD, Antinozzi PA, et al. Metabolomic profile associated with insulin resistance and conversion to diabetes in the insulin resistance atherosclerosis study. J Clin Endocrinol Metabol. 2015;100:E463–E468.
   PubMed Web of Science ®Google Scholar
• Tillin T, Hughes AD, Wang Q, et al. Diabetes risk and amino acid profiles: cross-sectional and prospective analyses of ethnicity, amino acids and diabetes in a South Asian and European cohort from the SABRE (Southall And Brent REvisited) study. Diabetologia. 2015;58:968–979.
   PubMed Web of Science ®Google Scholar
• Yan-Do R, Duong E, Manning Fox JE, et al. A glycine-insulin autocrine feedback loop enhances insulin secretion from human beta-cells and is impaired in type 2 diabetes. Diabetes. 2016;65:2311–2321.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Ortiz M, Medina-Santillan R, Martinez-Abundis E, et al. Effect of glycine on insulin secretion and action in healthy first-degree relatives of type 2 diabetes mellitus patients. Horm Metab Res. 2001;33:358–360.
   PubMed Web of Science ®Google Scholar
• Cochrane WA, Payne WW, Simpkiss MJ, et al. Familial hypoglycemia precipitated by amino acids. J Clin Invest. 1956;35:411–422.
   PubMed Web of Science ®Google Scholar
• Sekhar RV, McKay SV, Patel SG, et al. Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care. 2011;34:162–167.
   PubMed Web of Science ®Google Scholar
• Takashina C, Tsujino I, Watanabe T, et al. Associations among the plasma amino acid profile, obesity, and glucose metabolism in Japanese adults with normal glucose tolerance. Nutr Metab (Lond). 2016;13:5.
   PubMed Web of Science ®Google Scholar
• El Hafidi M, Perez I, Zamora J, et al. Glycine intake decreases plasma free fatty acids, adipose cell size, and blood pressure in sucrose-fed rats. Am J Physiol Regul Integr Comp Physiol. 2004;287:R1387–R1393.
   PubMed Web of Science ®Google Scholar
• Adeva MM, Calvino J, Souto G, et al. Insulin resistance and the metabolism of branched-chain amino acids in humans. Amino Acids. 2012;43:171–181.
   PubMed Web of Science ®Google Scholar
• Chevalier S, Marliss EB, Morais JA, et al. Whole-body protein anabolic response is resistant to the action of insulin in obese women. Am J Clin Nutr. 2005;82:355–365.
   PubMed Web of Science ®Google Scholar
• Mahendran Y, Jonsson A, Have CT, et al. Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels. Diabetologia. 2017;60:873–878.
   PubMed Web of Science ®Google Scholar
• O’Connell TM. The complex role of branched chain amino acids in diabetes and cancer. Metabolites. 2013;3:931–945.
   PubMedGoogle Scholar
• Lynch CJ, Adams SH. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol. 2014;10:723–736.
   PubMed Web of Science ®Google Scholar
• Burrage LC, Nagamani SC, Campeau PM, et al. Branched-chain amino acid metabolism: from rare Mendelian diseases to more common disorders. Hum Mol Genet. 2014;23:R1–R8.
   PubMed Web of Science ®Google Scholar
• Shin AC, Fasshauer M, Filatova N, et al. Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism. Cell Metab. 2014;20:898–909.
   PubMed Web of Science ®Google Scholar
• Morris C, O’Grada C, Ryan M, et al. The relationship between BMI and metabolomic profiles: a focus on amino acids. Proc Nutr Soc. 2012;71:634–638.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009;32(2):S157–S163.
   Google Scholar
• Koves TR, Ussher JR, Noland RC, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metabolism. 2008;7:45–56.
   PubMed Web of Science ®Google Scholar
• Zoppi CC, Silveira LR, Oliveira CA, et al. Insulin release, peripheral insulin resistance and muscle function in protein malnutrition: a role of tricarboxylic acid cycle anaplerosis. Br J Nutr. 2010; 103:1237–1250.
   PubMed Web of Science ®Google Scholar
• Drabkova P, Sanderova J, Kovarik J, et al. An assay of selected serum amino acids in patients with type 2 diabetes mellitus. Adv Clin Exp Med. 2015; 24:447–451.
   PubMed Web of Science ®Google Scholar
• Kelly A, Stanley CA. Disorders of glutamate metabolism. Ment Retard Dev Disabil Res Rev. 2001;7:287–295.
   PubMedGoogle Scholar
• Otter S, Lammert E. Exciting times for pancreatic islets: glutamate signaling in endocrine cells. Trends Endocrinol Metabol. 2016;27:177–188.
   PubMed Web of Science ®Google Scholar
• Bertrand G, Gross R, Puech R, et al. Glutamate stimulates glucagon secretion via an excitatory amino acid receptor of the AMPA subtype in rat pancreas. Eur J Pharmacol. 1993;237:45–50.
   PubMed Web of Science ®Google Scholar
• Adams SH. Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv Nutr (Bethesda, MD). 2011;2:445–456.
   PubMed Web of Science ®Google Scholar